Notably, among the pathogenic variants, the de novo DmisB identified in exon 2 of NFIX prompted us to reassess the phenotype of the proband in Fam81, leading to a clinical diagnosis of Malan syndrome. This evidence concerns the gene NFIX and Malan overgrowth syndrome.